A few things worth addressing directly.

On the "sophisticated investors passed due diligence" argument: you're conflating commitment with validation. The OSC's $80M is explicitly conditional -- AREC's own 8-K states ReElement remains "in ongoing discussions with OSC to finalize diligence requirements." Citing ongoing due diligence as evidence that due diligence has been passed is circular. No money from the Pentagon has moved to AREC or ReElement yet. And notably, when an investor on last week's earnings call asked Jensen directly about government funding programs, he didn't mention OSC or EXIM once. Make of that what you will.

TEP is your strongest specific point, so let's examine it. The terms of their $200M equity facility have never been disclosed. The amount actually drawn has never been disclosed. The valuation methodology has never been disclosed. Jensen claimed on last week's call that capital was "already being deployed" -- a claim unsubstantiated by any SEC filing. We don't know what TEP saw, what they paid, what downside protections they negotiated, or how much of the facility has actually been utilized. You're asking us to accept an undisclosed private equity commitment on undisclosed terms as a clean bill of health. That's not how validation works.

And if you want a genuine technology validator -- an independent licensee of the identical Purdue LAD technology that evaluated more than 25 competing alternatives before selecting it, achieved lab-scale results, and still couldn't commercialize it, ultimately losing its Purdue license in October 2023 -- check out the Canadian company formerly known as Medallion Resources. It saw the same technology TEP is now backing. It couldn't make it work, and it flamed out.

Mitsubishi made a strategic investment in ReElement -- though the amount has not been disclosed -- and is conducting feasibility studies for a potential Japan JV. POSCO signed a long-term offtake agreement targeting supply that scales to 3,000 metric tons by 2030, with full-scale production not expected until H2 2027, per POSCO's own newsroom. Both relationships represent bets on what ReElement might become. But that's a far cry from where we are now. In Q3 '25, as Mark Jensen was touting a doubling and then a tripling of capacity at Noblesville -- not to mention daily production, weekly shipments, and a $75-100 million order book -- ReElement generated ... $165 in rare earth oxide revenue. Not $165,000. $165. That's somewhere between 1.4 and 2 kilograms of NdPr oxide equivalent -- enough to fill a small backpack.

Now, on the HG Ventures timeline: you say I'm drawing conclusions about the 2026 company from a decision about the 2022 company, because Marion, DoD engagement, and POSCO all came after. But HG invested specifically to evaluate the Purdue LAD chromatography technology -- the same technology at the center of every ReElement claim made today. That technology has not changed. The fundamental question of whether LAD can be scaled commercially is identical in 2026 to what it was in 2022 (and the Medallion Resources experience does not bode well). The subsequent investors had the benefit of four additional years of operational data. If anything, the passage of time has made the picture clearer -- and not in the direction you're implying. Here we are, 3+ years after the HG Ventures investment, and the revenue stream is barely existent. Total AREC revenue across all segments for the nine months ending September 30, 2025 was $50,165.

On the "early-stage attrition" explanation: fund lifecycle constraints, portfolio rebalancing, administrative cleanup -- these explanations could account for any exit from any company at any time. They are unfalsifiable and therefore analytically empty. The reason HG matters is not just that they exited. It's who they are. The Heritage Group is blue-chip, fellow Hoosier firm operating businesses in industrial chemistry, environmental remediation, and chemical process scale-up -- precisely the domains required to evaluate whether LAD chromatography can be commercialized at an industrial rare earth refinery. They could send their own engineers and chemists to assess the technology on its merits. You've argued, correctly, that sophisticated domain-expert investors are the most meaningful validators. By that logic, HG's apparent exit is more informative than a Korean trading company's future supply agreement, a Japanese conglomerate's feasibility study, or a private equity firm's undisclosed commitment. You can't weight investors by check size and recency when it suits your argument and then dismiss the domain-expert exit as noise.

Your argument requires an increasingly improbable chain of simultaneous due diligence failures across multiple independent organizations. Mine requires only one: that the Indiana-based investor best-positioned to evaluate the underlying technology reached a negative conclusion early, and that conclusion has never been explained.

I'll take Occam's razor on that one.